U.S. Market access strategy at the clinical stage for all companies considering a launch: A three-part series

The complexity of the U.S. market access landscape means that proving safety and efficacy is no longer a guarantee of commercial success. This three-part series will provide you with the...

EMEA Leadership Talks - Shaping the Future

In this webinar series, we look at how the COVID-19 pandemic, digitalization and a global focus on ESG have, and will continue, to redefine a range of industries and how we all do business...

Navigating new challenges of cross-border merger reviews

On Thursday, September 30, 2021, the Hogan Lovells Antitrust and Competition team discussed the new challenges of cross-border merger reviews, including heightened scrutiny across a...

Antitrust today: Emerging issues affecting the life sciences industry

On Friday, March 12, 2021, the Hogan Lovells Antitrust and Competition team discussed hot antitrust topics in the life sciences industry, including:

What biotech employers need to know about COVID vaccines and returning to the office

Members of Biotechnology Innovation Organization (BIO) are invited to join us for a webinar to discuss corporate planning for returning employees back to physical in-office work. John...

Pantheon 2020 - California Life Sciences Association

Beth Roberts, Robert Church, and Elizabeth Halpern presented at Pantheon 2020.

FDLI Introduction to Drug and Device Law and Regulation for Patient Organizations

Heidi Gertner presented at the Food and Drug Law Institute's Introduction to Drug and Device Law and Regulation for Patient Organizations virtual course.

Loading data